Modulation of PARP-1 Activity in a Broad Time Window Attenuates Memorizing Fear
Abstract
:1. Introduction
2. Results
2.1. Effect of Inhibition of PARP-1 Activation on Fear Conditioning
2.2. Effect of Inhibition of PARP-1 Activation on Fear Conditioning Immediately after Training
2.3. Long Term Effect of Inhibition of PARP-1 Activity on Fear Conditioning—A Day after Training
2.4. Directing PARP-1 Inhibition to a Specific Memory
2.4.1. Effects on Natural Spatial Memory (Object Recognition Test)
2.4.2. Effect of Attenuation of PARP Activity on a Following Different Traumatic Event (Predator Scent)
3. Discussion
4. Materials and Methods
4.1. Subjects
4.2. Behavioral Procedures
4.2.1. Fear Conditioning Model
4.2.2. Locomotor Test
4.2.3. Object Recognition Test
4.3. Surgery and Cannula Implantation
4.4. Intracranial Infusions
4.5. Intraperitoneal Injection
4.6. Verifying the Location of Intrabrain Injection
4.7. Histology
4.8. Statistical Analysis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bergstrom, H.C. The neurocircuitry of remote cued fear memory. Neurosci. Biobehav. Rev. 2016, 71, 409–417. [Google Scholar] [CrossRef]
- E Schafe, G.; Nader, K.; Blair, H.; E LeDoux, J. Memory consolidation of Pavlovian fear conditioning: A cellular and molecular perspective. Trends Neurosci. 2001, 24, 540–546. [Google Scholar] [CrossRef]
- Wang, X.; Li, M.; Zhu, H.; Yu, Y.; Xu, Y.; Zhang, W.; Bian, C. Transcriptional Regulation Involved in Fear Memory Reconsolidation. J. Mol. Neurosci. 2018, 65, 127–140. [Google Scholar] [CrossRef]
- Diergaarde, L.; Schoffelmeer, A.N.; De Vries, T.J. Pharmacological manipulation of memory reconsolidation: Towards a novel treatment of pathogenic memories. Eur. J. Pharmacol. 2008, 585, 453–457. [Google Scholar] [CrossRef]
- Gamache, K.; Pitman, R.K.; Nader, K. Preclinical Evaluation of Reconsolidation Blockade by Clonidine as a Potential Novel Treatment for Posttraumatic Stress Disorder. Neuropsychopharmacol. 2012, 37, 2789–2796. [Google Scholar] [CrossRef] [PubMed]
- Bocchio, M.; Nabavi, S.; Capogna, M. Synaptic Plasticity, Engrams, and Network Oscillations in Amygdala Circuits for Storage and Retrieval of Emotional Memories. Neuron 2017, 94, 731–743. [Google Scholar] [CrossRef] [PubMed]
- Warhaftig, G.; Sokolik, C.M.; Khermesh, K.; Lichtenstein, Y.; Barak, M.; Bareli, T.; Levanon, E.Y.; Yadid, G. RNA editing of the 5-HT2C receptor in the central nucleus of the amygdala is involved in resilience behavior. Transl. Psychiatry 2021, 11, 1–10. [Google Scholar] [CrossRef]
- Walker, D.L.; Davis, M. Role of the extended amygdala in short-duration versus sustained fear: A tribute to Dr. Lennart Heimer. Brain Struct. Funct. 2008, 213, 29–42. [Google Scholar] [CrossRef]
- Lingawi, N.W.; Laurent, V.; Westbrook, F.; Holmes, N.M. The role of the basolateral amygdala and infralimbic cortex in (re)learning extinction. Psychopharmacology 2018, 236, 303–312. [Google Scholar] [CrossRef]
- LeDoux, J.E. Emotion Circuits in the Brain. Annu. Rev. Neurosci. 2000, 23, 155–184. [Google Scholar] [CrossRef]
- Li, H.; A Penzo, M.; Taniguchi, H.; Kopec, C.D.; Huang, Z.J.; Li, B. Experience-dependent modification of a central amygdala fear circuit. Nat. Neurosci. 2013, 16, 332–339. [Google Scholar] [CrossRef] [PubMed]
- Gupte, R.; Liu, Z.; Kraus, W.L. PARPs and ADP-ribosylation: Recent advances linking molecular functions to biological outcomes. Genes Dev. 2017, 31, 101–126. [Google Scholar] [CrossRef] [Green Version]
- Chaudhuri, A.R.; Nussenzweig, A.R.C.A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat. Rev. Mol. Cell Biol. 2017, 18, 610–621. [Google Scholar] [CrossRef]
- Kraus, W.; Lis, J.T. PARP Goes Transcription. Cell 2003, 113, 677–683. [Google Scholar] [CrossRef] [Green Version]
- Goldberg, S.; Visochek, L.; Giladi, E.; Gozes, I.; Cohen-Armon, M. PolyADP-ribosylation is required for long-term memory formation in mammals. J. Neurochem. 2009, 111, 72–79. [Google Scholar] [CrossRef]
- Cohen-Armon, M.; Visochek, L.; Rozensal, D.; Kalal, A.; Geistrikh, I.; Klein, R.; Bendetz-Nezer, S.; Yao, Z.; Seger, R. DNA-Independent PARP-1 Activation by Phosphorylated ERK2 Increases Elk1 Activity: A Link to Histone Acetylation. Mol. Cell 2007, 25, 297–308. [Google Scholar] [CrossRef] [PubMed]
- Cohenarmon, M. PARP-1 activation in the ERK signaling pathway. Trends Pharmacol. Sci. 2007, 28, 556–560. [Google Scholar] [CrossRef] [PubMed]
- Herdegen, T.; Leah, J. Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 1998, 28, 370–490. [Google Scholar] [CrossRef]
- Buchwalter, G.; Gross, C.; Wasylyk, B. Ets ternary complex transcription factors. Gene 2004, 324, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Lax, E.; Friedman, A.; Massart, R.; Barnea, R.; Abraham, L.; Cheishvili, D.; Zada, M.; Ahdoot, H.; Bareli, T.; Warhaftig, G.; et al. PARP-1 is required for retrieval of cocaine-associated memory by binding to the promoter of a novel gene encoding a putative transposase inhibitor. Mol. Psychiatry 2016, 22, 570–579. [Google Scholar] [CrossRef]
- Brewin, C.R. Memory and Forgetting. Curr. Psychiatry Rep. 2018, 20, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Peterson, A.L.; Foa, E.B.; Resick, P.A.; Hoyt, T.V.; Straud, C.L.; Moore, B.A.; Favret, J.V.; Hale, W.J.; Litz, B.T.; Rogers, T.E.; et al. A Nonrandomized Trial of Prolonged Exposure and Cognitive Processing Therapy for Combat-Related Posttraumatic Stress Disorder in a Deployed Setting. Behav. Ther. 2020, 51, 882–894. [Google Scholar] [CrossRef] [PubMed]
- Milliken, C.S.; Auchterlonie, J.L.; Hoge, C.W. Longitudinal Assessment of Mental Health Problems Among Active and Reserve Component Soldiers Returning From the Iraq War. JAMA 2007, 298, 2141–2148. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kida, S. Reconsolidation/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSD. Psychopharmacol. 2019, 236, 49–57. [Google Scholar] [CrossRef] [Green Version]
- Zohar, J.; Yahalom, H.; Kozlovsky, N.; Cwikel-Hamzany, S.; Matar, M.A.; Kaplan, Z.; Yehuda, R.; Cohen, H. High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: Interplay between clinical and animal studies. Eur. Neuropsychopharmacol. 2011, 21, 796–809. [Google Scholar] [CrossRef]
- Clarke, M.J.; Mulligan, E.A.; Grogan, P.T.; Mladek, A.C.; Carlson, B.L.; Schroeder, M.A.; Curtin, N.J.; Lou, Z.; Decker, P.A.; Wu, W.; et al. Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines. Mol. Cancer Ther. 2009, 8, 407–414. [Google Scholar] [CrossRef] [Green Version]
- Phelps, E.A.; LeDoux, J.E. Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior. Neuron 2005, 48, 175–187. [Google Scholar] [CrossRef] [Green Version]
- Pape, H.-C.; Pare, D. Plastic Synaptic Networks of the Amygdala for the Acquisition, Expression, and Extinction of Conditioned Fear. Physiol. Rev. 2010, 90, 419–463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cohen-Armon, M.; Visochek, L.; Katzoff, A.; Levitan, D.; Susswein, A.J.; Klein, R.; Valbrun, M.; Schwartz, J.H. Long-Term Memory Requires PolyADP-ribosylation. Science 2004, 304, 1820–1822. [Google Scholar] [CrossRef]
- Vaiva, G.; Ducrocq, F.; Jezequel, K.; Averland, B.; Lestavel, P.; Brunet, A.; Marmar, C.R. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol. Psychiatry 2003, 54, 947–949. [Google Scholar] [CrossRef]
- Pitman, R.K.; Sanders, K.M.; Zusman, R.M.; Healy, A.R.; Cheema, F.; Lasko, N.B.; Cahill, L.; Orr, S.P. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol. Psychiatry 2002, 51, 189–192. [Google Scholar] [CrossRef]
- Taylor, F.; Cahill, L. Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: A case study. J. Trauma. Stress 2002, 15, 433–437. [Google Scholar] [CrossRef]
- Dębiec, J.; Ledoux, J. Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience 2004, 129, 267–272. [Google Scholar] [CrossRef]
- Ciocchi, S.; Herry, C.; Grenier, F.; Wolff, S.B.E.; Letzkus, J.; Vlachos, I.; Ehrlich, I.; Sprengel, R.; Deisseroth, K.; Stadler, M.B.; et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nat. Cell Biol. 2010, 468, 277–282. [Google Scholar] [CrossRef]
- Ennaceur, A.; Delacour, J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav. Brain Res. 1988, 31, 47–59. [Google Scholar] [CrossRef]
- Inaba, H.; Tsukagoshi, A.; Kida, S. PARP-1 activity is required for the reconsolidation and extinction of contextual fear memory. Mol. Brain 2015, 8, 63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alvarado, S.; Tajerian, M.; Suderman, M.; Machnes, Z.; Pierfelice, S.; Millecamps, M.; Stone, L.S.; Szyf, M. An epigenetic hypothesis for the genomic memory of pain. Front. Cell. Neurosci. 2015, 9, 88. [Google Scholar] [CrossRef]
- Hochberg, Z.; Feil, R.; Constancia, M.; Fraga, M.; Junien, C.; Carel, J.-C.; Boileau, P.; Le Bouc, Y.; Deal, C.L.; Lillycrop, K.; et al. Child Health, Developmental Plasticity, and Epigenetic Programming. Endocr. Rev. 2010, 32, 159–224. [Google Scholar] [CrossRef] [PubMed]
- Suomi, A.; Evans, L.; Rodgers, B.; Taplin, S.; Cowlishaw, S. Couple and family therapies for post-traumatic stress disorder (PTSD). Cochrane Database Syst. Rev. 2019, 2019, CD011257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Horesh, D.; Solomon, Z.; Keinan, G.; Ein-Dor, T. The clinical picture of late-onset PTSD: A 20-year longitudinal study of Israeli war veterans. Psychiatry Res. 2013, 208, 265–273. [Google Scholar] [CrossRef]
- Brewin, C.R.; Cloitre, M.; Hyland, P.; Shevlin, M.; Maercker, A.; Bryant, R.A.; Humayun, A.; Jones, L.M.; Kagee, A.; Rousseau, C.; et al. A review of current evidence regarding the ICD-11 proposals for diagnosing PTSD and complex PTSD. Clin. Psychol. Rev. 2017, 58, 1–15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leonetti, C.; Biroccio, A.; Graziani, G.; Tentori, L. Targeted therapy for brain tumours: Role of PARP inhibitors. Curr. Cancer Drug Targets 2012, 12, 218–236. [Google Scholar] [CrossRef]
- Szabó, C.; Dawson, V. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion. Trends Pharmacol. Sci. 1998, 19, 287–298. [Google Scholar] [CrossRef]
- Szabó, C.; Lim, L.; Cuzzocrea, S.; Getting, S.J.; Zingarelli, B.; Flower, R.J.; Salzman, A.L.; Perretti, M. Inhibition of poly (ADP-ribose) Synthetase Attenuates Neutrophil Recruitment and Exerts Antiinflammatory Effects. J. Exp. Med. 1997, 186, 1041–1049. [Google Scholar] [CrossRef] [Green Version]
- Ennaceur, A. One-trial object recognition in rats and mice: Methodological and theoretical issues. Behav. Brain Res. 2010, 215, 244–254. [Google Scholar] [CrossRef] [PubMed]
- Nie, B.; Chen, K.; Zhao, S.; Liu, J.; Gu, X.; Yao, Q.; Hui, J.; Zhang, Z.; Teng, G.; Zhao, C.; et al. A rat brain MRI template with digital stereotaxic atlas of fine anatomical delineations in paxinos space and its automated application in voxel-wise analysis. Hum. Brain Mapp. 2013, 34, 1306–1318. [Google Scholar] [CrossRef] [Green Version]
- Penning, T.D.; Zhu, G.-D.; Gandhi, V.B.; Gong, J.; Liu, X.; Shi, Y.; Klinghofer, V.; Johnson, E.F.; Donawho, C.K.; Frost, D.J.; et al. Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer. J. Med. Chem. 2008, 52, 514–523. [Google Scholar] [CrossRef] [PubMed]
- Donawho, C.K.; Luo, Y.; Luo, Y.; Penning, T.D.; Bauch, J.L.; Bouska, J.J.; Bontcheva-Diaz, V.D.; Cox, B.F.; Deweese, T.L.; Dillehay, L.E.; et al. ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models. Clin. Cancer Res. 2007, 13, 2728–2737. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Elharrar, E.; Dikshtein, Y.; Meninger-Mordechay, S.; Lichtenstein, Y.; Yadid, G. Modulation of PARP-1 Activity in a Broad Time Window Attenuates Memorizing Fear. Int. J. Mol. Sci. 2021, 22, 6170. https://doi.org/10.3390/ijms22126170
Elharrar E, Dikshtein Y, Meninger-Mordechay S, Lichtenstein Y, Yadid G. Modulation of PARP-1 Activity in a Broad Time Window Attenuates Memorizing Fear. International Journal of Molecular Sciences. 2021; 22(12):6170. https://doi.org/10.3390/ijms22126170
Chicago/Turabian StyleElharrar, Einat, Yahav Dikshtein, Sapir Meninger-Mordechay, Yehuda Lichtenstein, and Gal Yadid. 2021. "Modulation of PARP-1 Activity in a Broad Time Window Attenuates Memorizing Fear" International Journal of Molecular Sciences 22, no. 12: 6170. https://doi.org/10.3390/ijms22126170